Oltipraz for Liver Fat Reduction in Patients With Non-alcoholic Fatty Liver Disease Except for Liver Cirrhosis
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:October 6, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Non-Alcoholic Fatty Liver DiseaseLast Updated:October 6, 2022Completed
Condition(s):Acute BronchitisLast Updated:March 30, 2016Completed
Condition(s):Chronic Liver DiseaseLast Updated:January 27, 2015Completed
Condition(s):Peptic UlcerLast Updated:January 23, 2018Completed
Condition(s):Non-alcholic Fatty Liver DiseaseLast Updated:March 30, 2016Completed
Condition(s):Asthma and Allergic RhinitisLast Updated:April 29, 2015Completed
Condition(s):Alcoholic Fatty Liver Disease; Alcoholic HepatitisLast Updated:April 29, 2015Completed
Condition(s):Acute Exacerbation of Chronic BronchitisLast Updated:May 30, 2014Completed
Condition(s):Gastritis; Gastric UlcerLast Updated:May 30, 2014Completed
Condition(s):Chronic Liver DiseaseLast Updated:July 13, 2011Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.